The Analyst Landscape: 9 Takes On TransMedics Gr
Portfolio Pulse from Benzinga Insights
In the last three months, 9 analysts have published ratings on TransMedics Gr (NASDAQ:TMDX), with a mix of bullish and somewhat bullish sentiments. The average 12-month price target has risen by 25.18% to $137.22. Analysts have raised their price targets, reflecting positive market sentiment and strong financial performance, including a 133.07% revenue growth rate and high net margins.
July 15, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TransMedics Gr (NASDAQ:TMDX) has received predominantly bullish ratings from analysts, with a significant increase in the average 12-month price target to $137.22. The company's strong financial performance, including a 133.07% revenue growth rate and high net margins, has contributed to this positive sentiment.
The majority of analysts have given bullish ratings, and the average price target has increased significantly. This reflects strong market confidence in TransMedics Gr's financial health and growth prospects, driven by impressive revenue growth and high net margins.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100